What:

The Clinician's Guide to the Cancer Genomics Galaxy: SNPs, Panels and Beyond

6th Annual Clinical Cancer Genomics Conference

Hosted by City of Hope, Division of Clinical Cancer Genomics, in collaboration with The University of Chicago Department of Medicine & Biological Sciences.

When: 

Friday, February 24, 2017 & Saturday, February 25, 2017

Friday: 8 am to 5:30 pm
Friday night CCGCoP 15th Anniversary Dinner Gala, 6:30 to 9:30 pm
Saturday: 8 am to 5:30 pm

Overview: 

Identifying hereditary cancer predisposition through genomic cancer risk assessment (GCRA) allows for intensified measures to prevent cancers or detect them at an earlier, more treatable stage, and both germline and somatic/tumor testing may guide precision therapy. The rapid advances of next generation sequencing (NGS) technologies and market forces are driving a surge in demand for GCRA services across the nation, but few clinicians are adequately prepared with the knowledge and skills needed to address the complexities associated with multigene panel testing and approaches that combine tumor and germline genomic profiles. This two-day conference will bring a roster of nationally recognized speakers together with community-based clinicians from across the U.S. to explore the promise and challenge of incorporating NGS technologies into the landscape of personalized cancer risk assessment, treatment and preventive care.  

Learning Objectives:
At the conclusion of this activity attendees will be able to:
 
  • Review basic concepts in genetics, genomics and NGS technologies
  • Identify the benefits and limitations of applying NGS information into cancer genetic/genomic risk assessment
  • Examine the challenges related to broad genomic analyses, such as panels or exomes, that yield incidental findings  
  • Apply evidence-based cancer screening and prevention recommendations to clinical cases with pathogenic variants in moderate risk genes
  • Discern the significance of germline findings in somatic tumor testing
  • Recognize the importance of clinical-research collaborations to characterize lesser-known cancer risk genes

Target Audience

A targeted national attendance of physicians, nurses, genetic counselors and researchers engaged in clinical genetic/genomic cancer risk assessment services and translational genomics research across the U.S. and internationally


Registration Costs:

**All CCGCoP Members 

who register using their 

portal account will receive 

an automatic $50

discount**

Early Registration (11/28/2016 to 1/31/2017):

Physicians/PhDs: $300

Nurses/Genetic Counselors/Physician's Assistants: $200

Students/Fellows/Residents: $150

Registration (after 1/31/2017):

Physicians/PhDs: $375

Nurses/Genetic Counselors/Physician's Assistants: $275

Students/Fellows/Residents: $225


NOTE:  Registration fee includes breakfast and lunch on Friday and Saturday, and our Friday night Dinner Gala, celebrating the 15th Anniversary of the Intensive Course and Clinical Cancer Genomics Community of Practice

Registration Deadlines

The cutoff for all registration deadlines is 5:00 p.m. PST on 2/23/17.

Click Here to Register

*ATTENTION Clinical Cancer Genomics Community Research Network (CCGCRN) Collaborators! Please be sure to register for the CCGCRN Consortium Meeting (Thursday, February 23, 2017) BEFORE registering for this conference. 


Location Details:

City of Hope National Medical Center
Cooper Auditorium
1500 E. Duarte Road
Duarte, CA 91010

Conference Co-Directors:

Jeffrey N. Weitzel, MD
Chief, Division of Clinical Cancer Genomics
City of Hope National Medical Center

Kathleen R. Blazer, EdD, MS, LCGC
Clinical Assistant Professor
Division of Clinical Cancer Genomics
City of Hope

Olufunmilayo Falusi Olopade, MBBS, FACP, OON       
Walter L. Palmer Distinguished Service Professor
Department of Medicine and Human Genetics
Associate Dean for Global Health

Iris Romero, MD, MS
Assistant Professor of Obstetrics & Gynecology
Center for Clinical Cancer Genetics
The University of Chicago